Osimo, Emanuele F. http://orcid.org/0000-0001-6239-5691
Perry, Benjamin I. http://orcid.org/0000-0002-1533-026X
Mallikarjun, Pavan
Pritchard, Megan
Lewis, Jonathan
Katunda, Asia
Murray, Graham K. http://orcid.org/0000-0001-8296-1742
Perez, Jesus
Jones, Peter B. http://orcid.org/0000-0002-0387-880X
Cardinal, Rudolf N. http://orcid.org/0000-0002-8751-5167
Howes, Oliver D.
Upthegrove, Rachel http://orcid.org/0000-0001-8204-5103
Khandaker, Golam M.
Article History
Received: 20 May 2022
Accepted: 3 November 2022
First Online: 19 January 2023
Competing interests
: O.D.H. is a part-time employee of H. Lundbeck A/S. He has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Angelini, Autifony, Biogen, Boehringer Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Janssen, H. Lundbeck A/S, Neurocrine, Otsuka, Sunovion, Recordati, Roche and Viatris/Mylan. O.D.H. has a patent for the use of dopaminergic imaging. R.N.C. consults for Campden Instruments and receives royalties from Cambridge Enterprise, Routledge and Cambridge University Press. The other authors declare no competing interests.